Probiotic-loaded microcapsule system for human in situ folate production: Encapsulation and system validation

• Folic acid has inefficient absorption, whilst natural forms have better uptake.
• Coated microcapsules are able to protect probiotics against the harsh conditions of the stomach.
• Coated microcapsules are able to exchange nutrients allowing probiotics activation.
• Coated microcapsules are able to adhere to epithelial cells.

This study focused on the use of a new system, an alginate | Ɛ-poly-l-lysine | alginate | chitosan microcapsule (APACM), able to immobilize a folate-producing probiotic, Lactococcus lactis ssp. cremoris (LLC), which provides a new approach to the utilization of capsules and probiotics for in situ production of vitamins. LLC is able to produce 95.25 ± 26 μg·L− 1 of folate, during 10 h, and was encapsulated in the APACM. APACM proved its capacity to protect LLC against the harsh conditions of a simulated digestion maintaining a viable concentration of 6 log CFU·mL− 1of LLC. A nutrients exchange capacity test, was performed using Lactobacillus plantarum UM7, a high lactic acid producer was used here to avoid false negative results. The production and release of 2 g·L− 1 of lactic acid was achieved through encapsulation of L. plantarum, after 20 h. The adhesion of APACM to epithelial cells was also quantified, yielding 38% and 33% of capsules adhered to HT-29 cells and Caco-2 cells, respectively.

Figure optionsDownload as PowerPoint slide